Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
NMR in Biomedicine
|
February 16, 2016
Quantitative agreement between [(15)O]H2O PET and model free QUASAR MRI-derived cerebral blood flow and arterial blood volume
D F R Heijtel, E T Petersen, H J M M Mutsaerts, et al.
Neuroimage. Clinical
|
January 5, 2021
Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study
E E Wolters, M van de Beek, R Ossenkoppele, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 3, 2021
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
J J Eertink, A I J Arens, J E Huijbregts, et al.
Blood
|
March 31, 2023
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
J J Eertink, G J C Zwezerijnen, M W Heymans, et al.
Blood Advances
|
May 4, 2021
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
J J Eertink, C N Burggraaff, M W Heymans, et al.
Molecular Imaging and Biology
|
February 13, 2015
Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany
D L Bailey, G Antoch, P Bartenstein, et al.
Nature Communications
|
November 9, 2018
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
A N Niemeijer, D Leung, M C Huisman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 10, 2019
[<sup>89</sup>Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
E J van Helden, S G Elias, S L Gerritse, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2020
Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
E J van Helden, S G Elias, S L Gerritse, et al.
Molecular Imaging and Biology
|
October 4, 2017
Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany
D L Bailey, B J Pichler, B Gückel, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
NMR in Biomedicine
|
February 16, 2016
Quantitative agreement between [(15)O]H2O PET and model free QUASAR MRI-derived cerebral blood flow and arterial blood volume
D F R Heijtel, E T Petersen, H J M M Mutsaerts, et al.
Neuroimage. Clinical
|
January 5, 2021
Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study
E E Wolters, M van de Beek, R Ossenkoppele, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 3, 2021
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
J J Eertink, A I J Arens, J E Huijbregts, et al.
Blood
|
March 31, 2023
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
J J Eertink, G J C Zwezerijnen, M W Heymans, et al.
Blood Advances
|
May 4, 2021
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
J J Eertink, C N Burggraaff, M W Heymans, et al.
Molecular Imaging and Biology
|
February 13, 2015
Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany
D L Bailey, G Antoch, P Bartenstein, et al.
Nature Communications
|
November 9, 2018
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
A N Niemeijer, D Leung, M C Huisman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 10, 2019
[<sup>89</sup>Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
E J van Helden, S G Elias, S L Gerritse, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 15, 2020
Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
E J van Helden, S G Elias, S L Gerritse, et al.
Molecular Imaging and Biology
|
October 4, 2017
Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany
D L Bailey, B J Pichler, B Gückel, et al.
Page
of 6